Adi Negev
Ofakim, South, Israel
Location status: Recruiting
Location contact
Dori Katz, DR
CONTACT
Ilanit Baum-Cohen, OT
SUB_INVESTIGATOR
Neta Kislev, OT
CONTACT
NCT Number: NCT06730074
The objective of this study is to test a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD). This pilot experiment will involve the collection of both subjective user evaluation measures and objective motor and cognitive measures.
Interested in participating?
Request Info50 year–75 year
All sexes
Interventional
Not applicable
Ofakim, South, Israel
Location status: Recruiting
Dori Katz, DR
CONTACT
Ilanit Baum-Cohen, OT
SUB_INVESTIGATOR
Neta Kislev, OT
CONTACT
Participants & Protocol:
Recruitment: Advertising ads in movement disorders units in hospitals and medical centers in the south, as well as through the help of the Parkinson's Association.
The study will be conducted with 15 PD patients, aged 50-75, at the Adi Negev Clinic. Each patient will use the robotic system five times, with each session lasting 30 minutes. The intervention plan incorporates principles of effective rehabilitation practice, including repeated practice, goal-oriented practice, variable difficulty, rhythmic cueing, and social interaction. Before the research begins, participants will sign an informed consent form.
Baseline and Pre-Post Tests:
Assessments including the MoCA, demographic data, clinical data, Color Trails Test (CTT), motor UPDRS, Box & Blocks Test, and Cognitive Reserve Index Questionnaire (CRIq) will be collected before the first session by an occupational or physical therapist. After the fifth session, post-intervention assessments will include motor UPDRS, Box & Blocks Test, CTT, System Usability Scale (SUS), Intrinsic Motivation Inventory (IMI), and a satisfaction questionnaire.
Hypothesis:
It is hypothesized that motor and cognitive training using the robots will improve the patients' clinical symptoms, as evidenced by pre-post test results.
Novelty & Impact:
This is the first socially assistive robotic platform developed specifically for people with PD. If successful, this platform could be incorporated into the clinical toolbox at Adi Negev and other centres. Additionally, this study will be the first to use the Cognitive Reserve Index Questionnaire (CRIq) in Hebrew for people with PD. The potential impact of this project is twofold: testing a new rehabilitation tool and a screening tool for PD patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is the first socially assistive robotic platform developed specifically for people with PD. If successful, this platform could be incorporated into the clinical toolbox at Adi Negev and other centres.
Time frame: 2 Mon
We will ask participants to rate their perceived level of engagement with the platform.
Time frame: 4 Mon
We will perform post-intervention assessments which include motor UPDRS (Unified Parkinson Disease Rating Scale)
Time frame: 4 Mon
We will perform post-intervention assessments which include Box and Blocks Test for fine motor coordination.
Time frame: 4 Mon
We will perform post-intervention assessments which include CTT (Color Trail Test) for executive functions.
Time frame: 4 Mon
We will perform post-intervention assessments which include System Usability Scale (SUS).
Time frame: 4 Mon
We will perform post-intervention assessments which include the Intrinsic Motivation Inventory (IMI).
Contact information is provided by the study sponsor or research team.
Dori Katz, Medical Doctor
CONTACT
Ilanit Baum Cohen, Msc. OT
CONTACT
Adi Negev-Nahalat Eran
Other
Acronym: PD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06680830
Basal Ganglia Diseases, Brain Diseases
Sun City, Arizona, United States
View Trial DetailsNCT07026734
Basal Ganglia Diseases, Behavior
Gainesville, Florida, United States
View Trial DetailsNCT07580612
Artifical Intelligence, Basal Ganglia Diseases
Leuven, Belgium
View Trial DetailsNCT04731246
Basal Ganglia Diseases, Brain Diseases
Monaco
View Trial Details